The global market for chromatography resin in drug discovery is
projected to grow from USD 290.7 million in 2017 to USD 401.1 million by
2022, at a CAGR of 6.65% from 2017 to 2022.

Factors such as the growing demand for therapeutic antibodies and rising
R&D in biopharmaceuticals are expected to drive the market. The key
constraint for the growth of this market is the lack of adequately
skilled professionals.

The ion exchange segment is expected to account for the largest share of
the chromatography resin market in drug discovery, in terms of volume.
This high share can be attributed to the increasing demand for this
technique in the pharmaceutical industry owing to the increasing need
for efficient separation methods.

The synthetic polymer segment is projected to grow at the highest CAGR
during the forecast period. The demand for synthetic polymers is
expected to be driven by their use in ion exchange chromatography.
Polystyrene divinylbenzene is the most commonly used synthetic polymer,
which is being increasingly used in ion exchange applications because of
its better performance in comparison to natural polymer.
Industrial-scale purification of biopharmaceuticals and quantitative and
qualitative analysis of drugs are the key application areas of
chromatography resin.